Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US green light for Medtronic cobalt stent:

This article was originally published in Clinica

Executive Summary

Medtronic today (October 2 2003) received FDA approval to market its Driver coronary stent in the US. The premarket approval (PMA) covers use of the stent for improving coronary luminal diameter in patients with de novo or restenotic lesions in vessels with diameters of 3-4mm, and less than or equal to 30mm in length. It is made of a cobalt-based alloy, allowing thinner struts than steel equivalents. The Driver stent is already in use in Europe where it has 29% market share for vessels 3mm and above, making it the leading cobalt alloy stent in Europe, according to Medtronic.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT063789

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel